{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:07:08Z","timestamp":1761844028242,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpba.2011.01.018","type":"journal-article","created":{"date-parts":[[2011,1,23]],"date-time":"2011-01-23T04:19:15Z","timestamp":1295756355000},"page":"187-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Rapid and simultaneous measurement of midazolam, 1\u2032-hydroxymidazolam and digoxin by liquid chromatography\/tandem mass spectrometry: Application to an in vivo study to simultaneously measure P-glycoprotein and Cytochrome P450 3A activity"],"prefix":"10.1016","volume":"55","author":[{"given":"Xinping","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huichang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.01.018_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jpba.2011.01.018_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1018877803319","article-title":"Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein","volume":"16","author":"Kim","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2011.01.018_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0736-4679(97)00022-X","article-title":"Midazolam: a review of therapeutic uses and toxicity","volume":"15","author":"Nordt","year":"1997","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.jpba.2011.01.018_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4","volume":"36","author":"Kronbach","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.018_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1753425908095956","article-title":"Changes of midazolam pharmacokinetics in Wistar rats treated with lipopolysaccharide: relationship between total CYP and CYP3A2","volume":"14","author":"Kato","year":"2008","journal-title":"Innate Immun."},{"key":"10.1016\/j.jpba.2011.01.018_bib0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/0091270006292625","article-title":"Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities","volume":"46","author":"Kirby","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.018_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/000331979204300401","article-title":"Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure","volume":"43","author":"Klein","year":"1992","journal-title":"Angiology"},{"key":"10.1016\/j.jpba.2011.01.018_bib0040","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0022-3565(25)39349-3","article-title":"Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney","volume":"266","author":"Hori","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2011.01.018_bib0045","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11095-005-7415-5","article-title":"Modification of the P-glycoprotein dependent pharmacokinetics of digoxin in rats by human recombinant interferon-alpha","volume":"22","author":"Ben","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2011.01.018_bib0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/15376510701190755","article-title":"Effect of repeated low-dose organophosphorothionate pesticide exposure on digoxin pharmacokinetics in rats; a possible interaction involving P-glycoprotein","volume":"17","author":"Cem","year":"2007","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.jpba.2011.01.018_bib0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jchromb.2007.02.034","article-title":"HPLC determination of midazolam and its three hydroxy metabolites in perfusion medium and plasma from rats","volume":"852","author":"Jurica","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.018_bib0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1248\/bpb.32.717","article-title":"A simplified method to determine five cytochrome p450 probe drugs by HPLC in a single run","volume":"32","author":"Liu","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2011.01.018_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchromb.2007.03.032","article-title":"Simultaneous analysis of cytochrome P450 probes-dextromethorphan, flurbiprofen and midazolam and their major metabolites by HPLC\u2013mass-spectrometry\/fluorescence after single-step extraction from plasma","volume":"853","author":"Kumar","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.018_bib0070","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/rcm.2987","article-title":"Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography\/electrospray ionization ion trap tandem mass spectrometry","volume":"21","author":"Link","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.01.018_bib0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpba.2003.12.023","article-title":"A sensitive HPLC\u2013MS-MS assay for quantitative determination of midazolam in dog plasma","volume":"35","author":"Harris","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.01.018_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2005.03.015","article-title":"Determination of midazolam and its major metabolite 1\u2032-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children","volume":"821","author":"Muchohi","year":"2005","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.018_bib0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1248\/bpb.25.422","article-title":"Development of radioimmunoassay for measurement of serum digoxin in digitalized patients using novel anti-digoxin antiserum","volume":"25","author":"Ikeda","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2011.01.018_bib0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007691-199702000-00021","article-title":"A simple, automated, nonextraction assay for serum digoxin using particle-enhanced immunoassay","volume":"19","author":"Davey","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2011.01.018_bib0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0731-7085(03)00226-7","article-title":"HPLC method with UV detection for evaluation of digoxin tablet dissolution in acidic medium after solid-phase extraction","volume":"33","author":"Jedlicka","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.01.018_bib0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchromb.2004.09.047","article-title":"Simultaneous determination of digoxin and permeability markers in rat in situ intestinal perfusion samples by RP-HPLC","volume":"813","author":"Varma","year":"2004","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.018_bib0105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0731-7085(03)00050-5","article-title":"A rapid and sensitive LC\/MS\/MS assay for quantitative determination of digoxin in rat plasma","volume":"32","author":"Yao","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.01.018_bib0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchromb.2008.05.026","article-title":"Validation and application of a 96-well format solid-phase extraction and liquid chromatography\u2013tandem mass spectrometry method for the quantitation of digoxin in human plasma","volume":"869","author":"Hashimoto","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.01.018_bib0115","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2011.01.018_bib0120","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/rcm.2422","article-title":"High-throughput determination of carbocysteine in human plasma by liquid chromatography\/tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers","volume":"20","author":"Bi","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:47:05Z","timestamp":1759999625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0731708511000434"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.01.018","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and simultaneous measurement of midazolam, 1\u2032-hydroxymidazolam and digoxin by liquid chromatography\/tandem mass spectrometry: Application to an in vivo study to simultaneously measure P-glycoprotein and Cytochrome P450 3A activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2011.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}